Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leukemia, B-Cell × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Colonic Neoplasms 3 Rectal Neoplasms 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vitamin D Deficiency 1 Renal Insufficiency, Chronic 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Osteoporosis 1 Obesity 1 Neurofibromatosis 1 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, B-Cell 1 Leukemia 1 Healthy, no Evidence of Disease 1 Congenital Abnormalities 1 Cardiovascular Diseases 1 Bone Diseases, Metabolic 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

ofatumumab 2 Vincristine 2 Lenalidomide 2 pomalidomide 1 pivalyloxymethyl butyrate 1 pegaspargase 1 nelarabine 1 fludarabine 1 bempegaldesleukin 1 Whole-Body Irradiation 1 Tablets 1 Rituximab 1 Panobinostat 1 Observation 1 Nivolumab 1 Mitoxantrone 1 Methotrexate 1 Mercaptopurine 1 Everolimus 1 Etoposide 1 Dexamethasone 1 DTRMWXHS-12 1 Cytarabine 1 Cyclophosphamide 1 Clofarabine 1 Cladribine 1 Cholecalciferol 1 Chlorambucil 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01518959 2020-07-16

D-HEM

Semmelweis University

Phase 3 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡